INDEMNIFICATION AGREEMENTIndemnification Agreement • July 19th, 2021 • Amplitude Healthcare Acquisition Corp • Biological products, (no disgnostic substances) • Delaware
THIS INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into as of ____________ between Jasper Therapeutics, Inc., a Delaware corporation (the “Company”), and ______________ (“Indemnitee”).
MATERIAL TRANSFER AGREEMENTMaterial Transfer Agreement • July 19th, 2021 • Amplitude Healthcare Acquisition Corp • Biological products, (no disgnostic substances) • New York
This Material Transfer Agreement (this “Agreement”) is made and entered into as of December 14, 2020 (the “Effective Date”) between Jasper Therapeutics, Inc., a Delaware corporation with a principal place of business at 2200 Bridge Parkway, Suite #102, Redwood City, CA 94065 (“Jasper”), and Zai Lab Limited, Cayman Islands corporation with a principal place of business at 4560 Jinke Road, Bldg. 1, 4F, Pudong, Shanghai, China 201210 (“Zai Lab”). Jasper and Zai Lab are referred to each as a “Party” or collectively as the “Parties”, respectively.
Intramural Clinical Trial AgreementAmplitude Healthcare Acquisition Corp • July 19th, 2021 • Biological products, (no disgnostic substances) • District of Columbia
This Agreement sets forth the terms and conditions under which this protocol will be conducted and the clinical trial will be managed.
JASPER THERAPEUTICS, INC. CONSULTING AGREEMENT Effective Date: _______ December 16, 2019 ___Consulting Agreement • July 19th, 2021 • Amplitude Healthcare Acquisition Corp • Biological products, (no disgnostic substances) • Delaware
